Light Chain Bioscience (Switzerland)

Light Chain Bioscience (Switzerland)

Novimmune is a privately held Swiss pharmaceutical development company focusing on monoclonal antibody therapies for treatment of immune-related diseases. The company was founded in 1998. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Light Chain Bioscience (Switzerland), Switzerland, covering academic research published from 2002 to 2023. Read More.


Open Access Percentage

64%


Total
Publications

271


Total Open
Publications

173


Total
Citations

14K


Open Access
Percentage

64%


Total
Publications

271


Total Open
Publications

173


Total
Citations

14K

Wikipedia

Website

download

Breakdown

19% 38% 7% 36%

Publisher Open

19%

Both

38%

Other Platform Open

7%

Closed

36%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416182022242628Total Publications
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

41%OA Journal

OA Journal 41%

64

Hybrid 17%

26

No Guarantees 42%

65

Other Platform Open

Domain 88%

106

Institution 35%

42

Public 14%

17

Other Internet 8%

10

Preprint 2%

3

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
108
Europe PMC
Domain
75
Figshare
Public
17
Semantic Scholar
Public
15
University of Zurich - Zurich Open Repository and Archive
Institution
12
University of Geneva - Archive ouverte UNIGE
Institution
12
ETH Zurich - Repository for Publications and Research Data
Institution
5
DOI
Other Internet
4
The University of Glasgow - Enlighten: Publications
Institution
3
University of Oxford - Oxford University Research Archive (ORA)
Institution
2
1 / 6

Data updated 7 October 2024

Share

Share

Share